Glaxo SmithKline Pharmaceuticals (GSK) is slated to annonuce its 4QCY2012 results today.

Commenting on the expectations, Angel Broking said, ''We expected to post net sales of Rs 6.8 bn. The gross margins are expected to be around 57.4% and the OPMs are expected to come to 26.8%. Overall, the net profit came in at Rs 1.32 billion, a dip of 10.1%. We recommend a 'Neutral' on the stock.''

Disclaimer: IRIS has taken due care and caution in compilation of data for its web site. Information has been obtained by IRIS from sources which it considers reliable. However, IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website.